High-Level Resistance of Toxigenic Clostridioides difficile Genotype to Macrolide-Lincosamide- Streptogramin B in Community Acquired Patients in Eastern China

References

• Bacci S, Molbak K, Kjeldsen MK, Olsen KE. Binary toxin and death after Clostridium difficile infection. Emerg Infect Dis. 2011;17(6):976–982. doi:10.3201/eid/1706.10148321749757
   PubMed Web of Science ®Google Scholar
• Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol. 2009;7(7):526–536. doi:10.1038/nrmicro216419528959
   PubMed Web of Science ®Google Scholar
• Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile—associated diarrhea. J Infect Dis. 2008;197(3):435–438. doi:10.1086/58691218199029
   PubMed Web of Science ®Google Scholar
• Jangi S, Lamont JT. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr. 2010;51(1):2–7. doi:10.1097/MPG.0b013e3181d2976720512057
   PubMed Web of Science ®Google Scholar
• Solomon K, Martin AJ, O’Donoghue C, et al. Mortality in patients with Clostridium difficile infection correlates with host pro-inflammatory and humoral immune responses. J Med Microbiol. 2013;62(Pt 9):1453–1460. doi:10.1099/jmm.0.058479-023722431
   PubMed Web of Science ®Google Scholar
• Brandt LJ. American journal of gastroenterology lecture: intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection. Am J Gastroenterol. 2013;108(2):177–185. doi:10.1038/ajg.2012.45023318479
   PubMed Web of Science ®Google Scholar
• Simor AE. Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review. J Am Geriatr Soc. 2010;58(8):1556–1564. doi:10.1111/j.1532-5415.2010.02958.x20646106
   PubMed Web of Science ®Google Scholar
• Vedantam G, Clark A, Chu M, McQuade R, Mallozzi M, Viswanathan VK. Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response. Gut Microbes. 2012;3(2):121–134. doi:10.4161/gmic.1939922555464
   PubMed Web of Science ®Google Scholar
• Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–455. doi:10.1086/65170620307191
   PubMed Web of Science ®Google Scholar
• Peng Z, Jin D. Update on antimicrobial resistance in Clostridium difficile: resistance mechanisms and antimicrobial susceptibility testing. J Clin Microbiol. 2017;55(7):1998–2008. doi:10.1128/JCM.02250-1628404671
   PubMed Web of Science ®Google Scholar
• Drudy D, Goorhuis B, Bakker D, et al. Clindamycin-resistant clone of Clostridium difficile PCR ribotype 027, Europe. Emerg Infect Dis. 2008;14(9):1485–1487. doi:10.3201/eid1409.07134618760028
   PubMed Web of Science ®Google Scholar
• Kuijper EJ, Barbut F, Brazier JS, et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveillance. 2008;13(31):18942.18761903
   PubMedGoogle Scholar
• Pituch H, Van Belkum A, Van Den Braak N, et al. Recent emergence of an epidemic clindamycin-resistant clone of Clostridium difficile among Polish patients with C. difficile-associated diarrhea. J Clin Microbiol. 2003;41(9):4184–4187. doi:10.1128/JCM.41.9.4184-4187.200312958245
   PubMed Web of Science ®Google Scholar
• Tang C, Cui L, Xu Y, et al. The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis. Sci Rep. 2016;6:37865. doi:10.1038/srep3786527897206
   PubMed Web of Science ®Google Scholar
• Jin D, Luo Y, Huang C, et al. Molecular epidemiology of clostridium difficile infection in hospitalized patients in Eastern China. J Clin Microbiol. 2017;55(3):801–810. doi:10.1128/JCM.01898-1627974547
   PubMed Web of Science ®Google Scholar
• Ackermann G, Degner A, Cohen SH, Silva J Jr., Rodloff AC. Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile. J Antimicrob Chem. 2003;51(3):599–603. doi:10.1093/jac/dkg112
   Web of Science ®Google Scholar
• Huang H, Weintraub A, Fang H, Nord CE. Antimicrobial resistance in. Int J Antimicrob Agents. 2009;34(6):516–522. doi:10.1016/j.ijantimicag.2009.09.01219828299
   PubMed Web of Science ®Google Scholar
• (CLSI) CaLSI. Defining, establishing, and verifying reference intervals in the clinical laboratory: approved Guideline-Third Edition. 2010.
   Google Scholar
• Ichihara KBJ. IFCC committee on reference intervals and decision limits (C-RIDL). An appraisal of statistical proceduces used in derivation of reference intervals. Clin Chem Lab Med. 2010;48:1537–1551. doi:10.1515/CCLM.2010.31921062226
   PubMed Web of Science ®Google Scholar
• Huang B, Jin D, Zhang J, et al. Real-time cellular analysis coupled with a specimen enrichment accurately detects and quantifies Clostridium difficile toxins in stool. J Clin Microbiol. 2014;52(4):1105–1111. doi:10.1128/JCM.02601-1324452160
   PubMed Web of Science ®Google Scholar
• Ryder AB, Huang Y, Li H, et al. Assessment of Clostridium difficile infections by quantitative detection of tcdB toxin by use of a real-time cell analysis system. J Clin Microbiol. 2010;48(11):4129–4134. doi:10.1128/JCM.01104-1020720023
   PubMed Web of Science ®Google Scholar
• McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene–variant strain of Clostridium difficile. N Eng J Med. 2005;353(23):2433–2441. doi:10.1056/NEJMoa051590
   PubMed Web of Science ®Google Scholar
• Griffiths D, Fawley W, Kachrimanidou M, et al. Multilocus sequence typing of Clostridium difficile. J Clin Microbiol. 2010;48(3):770. doi:10.1128/JCM.01796-0920042623
   PubMed Web of Science ®Google Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing. National Committee for Clinical and Laboratory Standards Wayne; 2017.
   Google Scholar
• He M, Miyajima F, Roberts P, et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet. 2013;45(1):109–113. doi:10.1038/ng.247823222960
   PubMed Web of Science ®Google Scholar
• Collins DA, Hawkey PM, Riley TV. Epidemiology of Clostridium difficile infection in Asia. Antimicrob Resist Infect Control. 2013;2(1):21. doi:10.1186/2047-2994-2-2123816346
   PubMed Web of Science ®Google Scholar
• Dong D, Peng Y, Zhang L, Jiang C, Wang X, Mao E. Clinical and microbiological characterization of Clostridium difficile infection in a tertiary care hospital in Shanghai, China. Chin Med J (Engl). 2014;127(9):1601–1607.24791861
   PubMed Web of Science ®Google Scholar
• Van den Berg RJ, Claas EC, Oyib DH, et al. Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping. J Clin Microbiol. 2004;42(3):1035–1041. doi:10.1128/JCM.42.3.1035-1041.200415004050
   PubMed Web of Science ®Google Scholar
• Zheng Y, Luo Y, Lv Y, et al. Clostridium difficile colonization in preoperative colorectal cancer patients. Oncotarget. 2017;8(7):11877–11886. doi:10.18632/oncotarget.1442428060753
   PubMedGoogle Scholar
• Johnson S, Samore MH, Farrow KA, et al. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Eng J Med. 1999;341(22):1645–1651. doi:10.1056/NEJM199911253412203
   PubMed Web of Science ®Google Scholar
• Kuijper EJ, de Weerdt J, Kato H, et al. Nosocomial outbreak of Clostridium difficile-associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain. Euro J Clin Microbiol & Infect Dis. 2001;20(8):528–534. doi:10.1007/s100960100550
   PubMed Web of Science ®Google Scholar